Latest / The Cancer Secrets Podcast / CSP S6E089 - Ep. 89, Prostate Cancer Success Story
Transcript
- 0:07Hi, and welcome to the Cancer Secrets podcast. I am your Host and guide,
- 0:10Dr. Jonathan Stegall. Cancer is like a thief who
- 0:14has come to steal, kill and destroy. I have personally seen
- 0:18it wreak its havoc on patients, friends, and even my own family.
- 0:22But I am on a mission to change the cancer paradigm through the practice of
- 0:26integrative oncology cancer treatment that integrates the best of
- 0:29conventional medicine with the best of alternative therapies. Backed
- 0:33by science and personalized to each patient. You
- 0:37need a positive voice you can trust. This podcast will share valuable
- 0:40information to give you practical hope for a better outcome.
- 0:44So I invite you to join me on this journey as we seek to change
- 0:47the cancer paradigm together.
- 0:52Hello and welcome back to the Cancer Secrets podcast. I'm your
- 0:55host, Dr. Jonathan Stegall. This is season six and
- 0:59episode number 89. In today's episode, I will be
- 1:02continuing our recent series on patient success stories.
- 1:06As many of you know, we have spent a considerable amount of time over the
- 1:10years of this podcast discussing research and treatment
- 1:13strategies for cancer. However, it recently dawned upon me that I
- 1:17had not spent much time illustrating what it looks like to put these principles
- 1:21into practice with actual patients. So several episodes ago,
- 1:25I decided to start sharing some of the wonderful outcomes I've seen using
- 1:28integrative oncology with patients in my practice. In episode
- 1:3287, we discussed an advanced ovarian cancer patient of mine who
- 1:36achieved no evidence of disease following integrative cancer
- 1:39treatment in my office. And in episode 88, I reviewed
- 1:43details of a wonderful outcome in a stage four breast cancer patient.
- 1:46In today's episode, I will be sharing a case report of a stage four
- 1:50prostate cancer patient. As always, the case details are
- 1:54real, but personal information has been changed in order to protect patient
- 1:57privacy. Today, we are discussing a male in his 70s.
- 2:01We will call him George. George came to me with stage four
- 2:05prostate cancer. He was initially diagnosed several years
- 2:09prior to meeting me when a biopsy showed an aggressive
- 2:12prostate cancer. For those of you who may not be aware, we
- 2:16grade prostate cancer using what is known as the Gleason score,
- 2:20and this is based on microscopic details seen by a pathologist.
- 2:24Samples of prostate cancer tissue are given a grade between 1 and
- 2:285. A score of 1 is the most similar to normal
- 2:31healthy prostate tissue and is therefore the least
- 2:34aggressive. And in contrast, A score of 5 is the most different
- 2:38from healthy prostate tissue and is thus more aggressive.
- 2:42Two different samples of prostate cancer tissue are graded, resulting in a
- 2:46Gleason score, which consists of the two scores added together.
- 2:50A Gleason score of 6 or less represents a cancer which is not very
- 2:54aggressive. Whereas a Gleason score of 7 is considered
- 2:57intermediate. Gleason scores of 8, 9 or 10
- 3:01are considered very aggressive. In the case of George, his
- 3:05Gleason score was a 4 + 5 = 9. His total score
- 3:09of 9 is considered a very aggressive cancer. So it was not surprising that
- 3:12he presented to me as a new patient with stage four or metastatic disease.
- 3:16It's also worth noting that upon diagnosis several
- 3:19years prior, he was found to have cancer throughout his prostate. George
- 3:23decided to pursue alternative cancer treatment initially.
- 3:26While I'm a huge fan of various alternative cancer treatments,
- 3:30it's generally a bad idea to rely exclusively on
- 3:33them for cancer treatment. He went to Europe and received
- 3:37various alternative treatments including ozone, vitamin infusions and
- 3:40hyperthermia. Unfortunately, George had minimal success
- 3:44from this and had to seek other treatment options.
- 3:47He returned to the United States and pursued radiation therapy.
- 3:51In this case, it consisted of radiation seeds implanted into
- 3:55the prostate. This is a fairly common method of radiation
- 3:59when the prostate has been found to have cancer in it. And these
- 4:03radiation seeds were then followed by a type of radiation called
- 4:06imrt, which stands for intensity modulated radiation
- 4:09therapy. Follow up imaging showed no evidence of disease, so he did
- 4:13have a good outcome from this radiation. Now, it's also worth noting that
- 4:17George was put on a medication called Lupron which is part of the standard
- 4:20of care for prostate cancer as well. This is a medication which lowers
- 4:24testosterone levels in the body and therefore deprives
- 4:28prostate cancer cells of testosterone, which we know is a
- 4:31preferred energy source of prostate cancer cells.
- 4:35George continued Lupron as a maintenance therapy for approximately two
- 4:39years, at which time he was found on follow up imaging to have a lymph
- 4:43node which appeared suspicious. His prostate specific
- 4:46antigen lab test, which we also refer to as a psa,
- 4:50began to rise. That was concerning for cancer
- 4:53recurrence. Now, it was around this time when George received a
- 4:57type of radiation therapy called proton therapy. This was designed to
- 5:01target the areas concerning for cancer. On imaging
- 5:04following proton therapy, George resumed Lupron which brought his
- 5:08PSA back under control. However, instead of having his
- 5:12next Lupron shot as scheduled, he elected to discontinue it.
- 5:15Not surprisingly, his PSA began to rise. When he presented to me
- 5:19as a new patient, his PSA was higher than it had ever been.
- 5:23He also had imaging just prior to seeing me. A PET-CT
- 5:26scan was notable for multiple lymph nodes of concern throughout his body,
- 5:30including lymph nodes in the abdomen, pelvis,
- 5:34chest and neck. Areas of concern Were also seen within
- 5:37the prostate gland itself. George came to me looking for an
- 5:41integrative approach. I felt that he was a great candidate for this because
- 5:45although he had implemented elements of both conventional cancer treatment
- 5:49as well as alternative cancer treatment, he had never truly
- 5:52combined them at the same time in a coordinated fashion. I was
- 5:56excited to take on George's case because I have found a really great
- 6:00synergy between conventional cancer treatments as well
- 6:03as alternative cancer treatments. My treatment protocol
- 6:07for George was as follows. First, I placed him on a
- 6:11chemotherapy regimen consisting of docetaxel plus
- 6:14liposomal doxorubicin. Docetaxel is a common
- 6:17chemotherapy agent used to treat metastatic prostate cancer, and
- 6:21it's typically a first line chemotherapy agent, Meaning it's
- 6:25typically the first one we choose. Docetaxel is also
- 6:29usually given as monotherapy, meaning that it's the only chemotherapy
- 6:32agent given. However, because I use much lower doses of
- 6:36chemotherapy compared to the standard of care, I can justify
- 6:40including a second chemotherapy agent at the same time. This
- 6:43is where the liposomal doxorubicin came in. As
- 6:47always, because these lower doses were used, I was able to administer them
- 6:51more often than the standard of care does. This is
- 6:54crucial, as we know that chemotherapy only kills cancer cells when they are
- 6:58in a state of active division. Cancer cells can easily
- 7:02transition from a state of dormancy into a state of active
- 7:05and vice versa. This process is chaotic and unpredictable,
- 7:09so each time we give chemotherapy, we are at the mercy of this
- 7:13randomness. The more times we can safely administer
- 7:16chemotherapy, the more likely we are to reach cancer cells
- 7:19when they are in this vulnerable state of active division. In addition to
- 7:23giving lower doses of chemotherapy, More often, I utilize what is known as
- 7:27insulin potentiation therapy, or IPT for short.
- 7:31Insulin is a biologic response modifier, and when cancer cells
- 7:35are exposed to insulin, they flip into a state of active division.
- 7:39When we time this with chemotherapy, our goal is to have a more
- 7:42vulnerable population of cancer cells. Of course, since
- 7:46insulin lowers blood sugar, we are very careful to balance this with
- 7:49intravenous dextrose so the patients do not experience low blood
- 7:53sugar. I have found this IPT process to be very safe and
- 7:57quite effective. In addition to the chemotherapy, I also put George
- 8:01on a medication called ELIGARD, which lowers testosterone levels
- 8:04and thus reduces one of prostate cancer's favorite fuel sources.
- 8:09As many of you know, I'm also a big believer in various supportive therapies, including
- 8:13mistletoe lymphatic therapy and targeted
- 8:16hyperthermia, or heat. These therapies were an excellent
- 8:19complement to the other aspects of George's protocol including
- 8:23chemotherapy and Eligard. As always, I utilize
- 8:27various repurposed medications and supplements in order to target additional
- 8:30cancer pathways which are not targeted by conventional cancer
- 8:34treatments such as chemotherapy. The goal here was to further
- 8:37stress George's cancer cells and reduce their viability.
- 8:41Finally, I put him on a plant focused diet as well as an appropriate
- 8:45exercise regimen. After completing my 12 week
- 8:48integrative cancer treatment program, George's PSA had plummeted to
- 8:52nearly undetectable levels. A follow up PET-CT scan
- 8:56showed complet resolution of the cancerous lymph nodes in his neck and chest.
- 9:00Significant improvement was seen in the lymph nodes in his abdomen and pelvis.
- 9:04Many of these concerning lymph nodes seen on prior imaging had completely
- 9:08resolved and others had improved considerably. In addition,
- 9:12the metabolic activity within the prostate had decreased notably as well.
- 9:16Based on a small amount of residual cancer remaining on imaging, I
- 9:20recommended that George receive four more weeks of integrative cancer
- 9:24treatment with me. This once again included chemotherapy using IPT
- 9:28as well as supportive therapies. Follow up imaging
- 9:31after these additional four weeks of treatment showed continued improvement including
- 9:35complete resolution of the remaining cancerous areas in the chest and abdomen.
- 9:39In addition, we continued monitoring PSA moving forward in the
- 9:43form of what is known as an ultra sensitive psa. This is
- 9:47a specialized version of a normal PSA which is designed for prostate cancer
- 9:51patients with extremely low PSA levels.
- 9:54George's level continued to remain low following treatment.
- 9:58Of course, as always, I made sure that we did not become complacent.
- 10:02George was maintained on a proactive regimen of repurposed medications,
- 10:06nutritional supplements, an anti cancer diet, a
- 10:09sensible exercise regimen and a protocol for stress management.
- 10:14I feel that these additional interventions are critical for helping
- 10:17maintain good results and improved internal terrain which was
- 10:21once hospitable to cancer. I hope you've enjoyed this
- 10:25integrative oncology case report. I'm excited to share these great
- 10:29outcomes with you and I plan to share even more in the future. Thank
- 10:33you again for being a faithful listener of this podcast. We have many
- 10:36great episodes coming ahead. Until next time, bye
- 10:39bye.